11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
The 2019 novel coronavirus continues to evolve and has been officially named COVID-19 by the World H...
Read More >
As we know, a temporary residence permit (razreshenie na vremennoye prozhivanie) confirms a foreign ...
Read More >
Due to a flood of requests, the Ohio Bureau of Workers’ Compensation (BWC) Board of Directors reque...
Read More >
The draft amending act to the Construction Law includes the solution the purpose of which is not onl...
Read More >
It is well established that policies of insurance are contracts, subject to basic contract law. Whil...
Read More >
Presented by Cohen Seglias attorneys Matthew Gioffre, Lisa Wampler, and Daniel E. Fierstein on Novem...
Read More >